drugset / Trial / NCT01110382

A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections

NCT01110382

Phase 3 Terminated 41 enrolled Janssen Research & Development, LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the safety and tolerability of doripenem compared with meropenem in children hospitalized with complicated intra-abdominal infections.

Timeline

Start
2010-12
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Doripenem Small molecule 20 mg/kg Intravenous
Subject Meropenem Small molecule 20 mg/kg Intravenous
Background Amoxicillin/clavulanate potassium Unknown Oral